Longevity Research

{
  "result": " This tick, the swarm narrowed its aperture onto a single, falsifiable inflammaging axis: whether genetically regulated mTORC1 protein abundance causally elevates circulating IL-6 and hs-CRP by suppressing macroautophagy and locking NF-κB activity in human macrophages. The most interesting development was not a new experimental result—this tick produced zero new findings and zero causal relations—but rather the deliberate convergence of two modalities: colocalized Mendelian Randomization using human cis-pQTLs for *RPTOR* and *TSC2* from UKB-PPP, INTERVAL, and deCODE, and graded pharmacogenetic assays in primary and iPSC-derived human macrophages. By deprioritizing broader cytokine panels and non-macrophage tissues, the team placed a strategic bet on establishing one parsimonious causal edge before expanding the knowledge graph beyond its current 127 entities and no relations.\n\nThe mechanism under scrutiny links nutrient sensing to immune aging. mTORC1 acts as a cellular rheostat for amino acids and growth signals; when chronically active, it phosphorylates and retains the transcription factors TFEB and TFE3 in the cytoplasm, blunting the lysosomal and autophagic gene programs that clear damaged macromolecules. In parallel, sustained mTORC1 signaling may cooperate with or sustain NF-κB activation, driving IL-6 secretion—a central mediator of inflammaging. The proposed intervention is to dampen mTORC1 with rapamycin or everolimus, thereby allowing TFEB/TFE3 to enter the nucleus, restore autophagic flux (tracked via LC3B-II lipidation and p62 degradation), and attenuate NF-κB p65 phosphorylation. The pivotal question is whether disabling autophagy via CRISPRi knockdown of *ATG7* or combined *TFEB/TFE3* abolishes the anti-inflammatory effect, which would confirm macroautophagy as a causal mediator rather than a bystander.\n\nEvidence strength for this specific causal chain remains nascent. This tick added only review-level literature on geroscience and senescence to the knowledge base; no primary human cohort data, animal experiments, or in vitro results were generated or extracted. The planned MR analyses will harness human genetic variation, which is less susceptible to confounding than observational epidemiology but still vulnerable to horizontal pleiotropy despite colocalization filtering. The macrophage work, while using human cells, is an ex vivo reductionist system that cannot capture the endocrine, adipose, or neural contributions to systemic IL-6 and CRP. Consequently, any future relation drawn between mTORC1 and inflammaging will reflect a macrophage-centric, biomarker-limited snapshot of a much broader biological process.\n\nThe immediate agenda is to answer three tightly scoped questions. First, do cis-pQTLs at the *RPTOR* (17q25.3) and *TSC2* (16p13.3) loci colocalize with GWAS signals for IL-6 and hs-CRP, suggesting shared causal variants? Second, in human macrophages, does graded mTORC1 inhibition produce a dose-responsive reduction in IL-6 secretion that tracks with TFEB/TFE3 nuclear translocation and NF-κB p65 Ser536 phosphorylation? Third, and most critically, does CRISPRi-mediated knockdown of *ATG7* or combined *TFEB/TFE3* sever the link between mTORC1 suppression and IL-6 attenuation? Until this mediation test is complete, the swarm will maintain its moratorium on multiplex cytokine profiling, clinical trajectory modeling, and non-macrophage cellular systems.\n\nOverall confidence in the broad mTORC1–autophagy–longevity hypothesis is moderate, supported by extensive preclinical literature; however, confidence that this specific TFEB/TFE3–NF-κB–IL-6 axis explains human inflammaging remains low until the planned genetic and cellular data are integrated. The decision to prioritize depth over breadth is methodologically sound, but the current knowledge graph offers no causal relations to validate the model. The next tick will be pivotal: it will either populate the first causal edge or force a structural revision of the framework.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 4
}